Short-course of ranolazine prevents postoperative atrial fibrillation following coronary artery bypass grafting and valve surgeries

Clinical Research in Cardiology

Volumn 104, Issue 5, 2015, Pages 410-417

  Hammond, Drayton A ^a,e   Smotherman, Carmen ^b   Jankowski, Christopher A ^a,c   Tan, Stephen ^a,c   Osian, Omeni ^d   Kraemer, Dale ^b   DeLosSantos, Marci ^a,c  

^a UNIVERSITY OF FLORIDA HEALTH JACKSONVILLE   (United States)

^b Center for Health Equity and Quality Research   (United States)

^c UNIVERSITY OF FLORIDA HEALTH   (United States)

^d UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Coronary artery bypass grafting; Heart valve surgery; Postoperative atrial fibrillation; Ranolazine

Indexed keywords

CARDIOVASCULAR AGENT; RANOLAZINE;

ADVERSE EFFECTS; AGED; ANNULOPLASTY; ATRIAL FIBRILLATION; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; FEMALE; GERMANY; HEART VALVE REPLACEMENT; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY;

AGED; ATRIAL FIBRILLATION; CARDIAC VALVE ANNULOPLASTY; CARDIOVASCULAR AGENTS; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GERMANY; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RANOLAZINE; RETROSPECTIVE STUDIES;

EID: 84940005297     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-014-0796-x     Document Type: Article

References (45)

1. Chung EH, Martin DT (2010) Management of postoperative arrhythmias. In: O’Donnell JM (ed) Surgical intensive care medicine. Springer, New York, pp 209–227
2. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL (1993) Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 56:539–549
3. Chung MK (2000) Cardiac surgery: postoperative arrhythmias. Crit Care Med. 28(Suppl):N136–N144
4. Maisel WH, Rawn JD, Stevenson WG (2001) Atrial fibrillation after cardiac surgery. Ann Intern Med 135:1061–1073
5. Heintz KM, Hollenberg SM (2005) Perioperative cardiac issues: postoperative arrhythmias. Surg Clin North Am 85:1103–1114
6. Yagdi T, Nalbantgil S, Ayik F, Apaydin A, Islamoglu F, Posacioglu H, Calkavur T, Atay Y, Buket S (2003) Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting. J Thorac Cardiovasc Surg 125:1420–1425
7. Giri S, White CM, Dunn AB, Felton K, Freeman-Bosco L, Reddy P, Tsikouris JP, Wilcox HA, Kluger J (2001) Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomized placebo-controlled trial. Lancet 357:830–836
8. Mitchell LB, Exner DV, Wyse DG, Connolly CJ, Prystai GD, Bayes AJ, Kidd WT, Kieser T, Burgess JJ, Ferland A, MacAdams CL, Maitland A (2005) Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair. JAMA 294:3093–3100
9. Daoud EG, Strickberger SA, Man KC, Goyal R, Deeb GM, Bolling SF, Pagani FD, Bitar C, Meissner MD, Morady F (1997) Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 337:1785–1791
10. Guarnieri T, Nolan S, Gottlieb SO, Dudek A, Lowry DR (1999) Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the amiodarone reduction in coronary heart (ARCH) trial. J Am Coll Cardiol 34:343–347
11. Miles RH, Passman R, Murdock DK (2011) Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 108:673–676
12. Bhave PD, Goldman LE, Vittinghoff E, Maselli J, Auerbach A (2012) Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery. Am Heart J 164:918–924
13. Maesen B, Nijs J, Maessen J, Allessie M, Schotten U (2012) Post-operative atrial fibrillation: a maze of mechanisms. Europace 14:159–174
14. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Mangano DT (2004) investigators of the ischemia research and education foundation; multicenter study of perioperative ischemia research group. a multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 291:1720–1729
15. Sun X, Hill PC, Lowery R, Lindsay J, Boyce SW, Bafi AS, Garcia JM, Haile E, Corso PJ (2011) Comparison of frequency of atrial fibrillation after coronary artery bypass grafting in African Americans versus European Americans. Am J Cardiol 108:669–672
16. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Heuzey JY, Ponikowski P, Rutten FH, ESC Committee for Practice Guidelines (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 12:1360–1420
17. January CT, Wann LS, Alpert JS, Calkins H, Cleveland JC Jr, Cigarroa JE, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW (2014) AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation [Epub ahead of print]
18. Tagarakis GI, Aidonidis I, Daskalopoulou SS, Simopoulos V, Liouras V, Daskalopoulos ME, Parisis C, Papageorgiou K, Skoularingis I, Triposkiadis F, Molyvdas PA, Tsilimingas NB (2013) Effect of ranolazine in preventing postoperative atrial fibrillation in patients undergoing coronary revascularization surgery. Curr Vasc Pharmacol 11:988–991
19. Simopoulos V, Tagarakis G, Hatziefthimiou A, Skoularigis I, Triposkiadis F, Trantou V, Tsilimingas N, Aidonidis I (2014) Effectiveness of aldosterone antagonists for preventing atrial fibrillation after cardiac surgery in patients with systolic heart failure: a retrospective study. Clin Res Cardiol [Epub ahead of print]
20. Fragakis N, Koskinas KC, Katritsis DG, Pagourelias ED, Zografos T, Geleris P (2012) Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset atrial fibrillation. Am J Cardiol 110:673–677
21. Vizzardi E, D’Aloia A, Quinzani F, Bonadei I, Rovetta R, Bontempi L, Curnis A, Dei Cas L (2012) A focus on antiarrhythmic properties of ranolazine. J Cardiovasc Pharmacol Ther 17:353–356
22. Burashnikov A, Di Diego JM, Zygmunt AC, Belardinelli L, Antzelevitch C (2007) Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation. Circulation 116:1449–1457
23. Sicouri S, Glass A, Belardinelli L, Antzelevitch C (2008) Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations. Heart Rhythm 5:1019–1026
24. Burashnikov A, Antzelevitch C (2013) Role of late sodium channel current block in the management of atrial fibrillation. Cardiovasc Drug Ther 27:79–89
25. Savelieva I, Camm J (2008) Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches. Europace 10:647–665
26. Scirica BM, Belardinelli L, Chaitman BR, Waks JW, Volo S, Karwatowska-Prokopczuk E, Murphy SA, Cheng ML, Braunwald E, Morrow DA (2014) Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. Europace [Epub ahead of print]
27. Sicouri S, Burashnikov A, Belardinelli L, Antzelevitch C (2010) Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria. Circ Arrhythm Electrophysiol 3:88–95
28. Burashnikov A, Sicouri S, Di Diego JM, Belardinelli L, Antzelevitch C (2010) Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation. J Am Coll Cardiol 56:1216–1224
29. Murdock DK, Overton N, Kersten M, Kaliebe J, Devecchi F (2008) The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation. Indian Pacing Electrophysiol J 8:175–181
30. Ranexa(R) [package insert]. Foster City, CA: Gilead Sciences, Inc; 2013
31. Burashnikov A, Di Diego JM, Barajas-Martínez H, Hu D, Zygmunt AC, Cordeiro JM, Moise NS, Kornreich BG, Belardinelli L, Antzelevitch C (2014) Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure. Circ Heart Fail 7(4):627–633
32. Frommeyer G, Schmidt M, Clauß C, Kaese S, Stypmann J, Pott C, Eckardt L, Milberg P (2012) Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure. Eur J Heart Fail 14(12):1322–1331
33. Zusman O, Amit G, Gilutz H, Zahger D (2012) The significance of new onset atrial fibrillation complicating acute myocardial infarction. Clin Res Cardiol 101(1):17–22
34. Camm AJ, et al. RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion). Heart Rhythm Society 2014 Scientific Sessions; May 10, 2014; San Francisco, CA. Lecture ID 9451
35. Sossalla S, Kallmeyer B, Wagner S, Mazur M, Maurer U, Toischer K, Schmitto JD, Seipelt R, Schöndube FA, Hasenfuss G, Belardinelli L, Maier LS (2010) Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. J Am Coll Cardiol 55(21):2330–2342
36. Sossalla S, Wallisch N, Toischer K, Sohns C, Vollmann D, Seegers J, Lüthje L, Maier LS, Zabel M (2014) Effects of ranolazine on torsades de pointes tachycardias in a healthy isolated rabbit heart model. Cardiovasc Ther 32(4):170–177
37. Bunch TJ, Mahapatra S, Murdock D, Molden J, Weiss JP, May HT, Bair TL, Mader KM, Crandall BG, Day JD, Osborn JS, Muhlestein JB, Lappe DL, Anderson JL (2011) Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks. Pacing Clin Electrophysiol 34(12):1600–1606
38. Yeung E, Krantz MJ, Schuller JL, Dale RA, Haigney MC (2014) Ranolazine for the suppression of ventricular arrhythmia: a case series. Ann Noninvasive Electrocardiol 19(4):345–350
39. Kowey PR, Reiffel JA, Camm AJ, et al. The effect of the combination of ranolazine and low dose dronedarone on atrial fibrillation burden in patients with paroxysmal atrial fibrillation (HARMONY trial). Heart Rhythm Society 2014 Scientific Sessions; May 10, 2014; San Francisco, CA. Abstract LB03-05
40. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL et al (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med 324(12):781–788
41. SAS Institute Inc. SAS Version 9.3 for Windows, Cary, NC: SAS Institute Inc.; 2008
42. Parsons LS, ed. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of the Twenty-Sixth Annual SAS Users Group International Conference. Long Beach, CA, 2001
43. Hogue CW Jr, Creswell LL, Gutterman DD, Fleisher LA, American College of Chest Physicians (2005) Epidemiology, mechanisms, and risks: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 128:9S–16S
44. Chelazzi C, Villa G, De Gaudio AR (2011) Postoperative atrial fibrillation. ISRN Cardiol 203179:1–10
45. Kim SJ, Depre C, Vatner SF (2003) Novel mechanisms mediating stunned myocardium. Heart Fail Rev 8:143–153